Download Decrease O 2 demand by venodilatation - e

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Vilasinee Hirunpanich
B.Pharm (Hon), M.Sc in Pharm
(Pharmacology)
Angina pectoris
 Imbalance of O2 demand and supply
 myocardial O2 consumption > O2 supply
symptoms
เจ็บแน่นหน้าอกเหมือนมีสิ่งมากด
ทับบริ เวณลิ้นปี่
อาจมีอาการปวดร้าวและแผ่
กระจายไปที่คอ ไหล่และแขนซ้าย
Pathophysiology
1. decrease coronary blood flow
coronary spasm
Atherosclerosis
Traumatic injury
Embolic event
2. Increase O2 demand
increase physical activity which result in the
increase of sympathetic activity
3. Reduce blood O2
 anemia
ปัจจัยที่มีผลต่อการทางานของหัวใจ
Oxygen demand
Oxygen supply
 heart rate
 myocardial blood flow
 contractility
 afterload
 preload
Type of angina pectoris
 Stable angina
 Unstable angina
 Variant angina (Prinzmetal’s angina)
Stable angina
Coronary artery spasm
Treatment goals
 Alleviate symptoms
 Control & modify risk factors
– Smoking, HT, DM, obesity, dyslipidemia, stress
 O2 supply and  O2 demand
 Pharmacologic therapy
– Nitrate, beta-blockers, CCB
 Intervention therapy
– PTCA
– CABG
กลุ่มยาหลักที่ใช้ในการรักษา
Organic nitrate
calcium channel blockers
beta-blocker
1. Organic Nitrate
Mechanism of action
 Internalized metablolite to…. NO
 Increase cGMP……smooth muscle
relaxation and vasodilatation
 Stimulate PGI & PGE2
 Antianginal effects
– Decrease O2 demand by venodilatation
– Increase O2 supply by coronary vasodilation
Mechanism of nitrate
Sulfhydryl group
nitrate
NO2
NO (active)
Stimulate guanylate cyclase
Stimulate cGMP
Decrease Ca level
vasodilation
Pharmacological effects
1. Smooth muscle relaxation
 Vein sensitive than arteries
 Venodilatation…..decrease ventricular
preload, pulmonary pressure (O2 demand)
SE>>>orthostatic hypotension, syncope
 Vasodilatation…..decrease peripheral
resistance (O2 demand)
SE>>> flushing, throbbing headache
Pharmacological effects (cont)
2. Smooth muscle relaxation at other
organ
Not widely use in clinic except
Sidenafil (Vigra)
3. Antiplatelet activity
decrease platelet aggregation
not widely use
Nicorandil stimulate K+ channel + NO
Pharmacological effects (cont)
4. Other effects
Methemoglobin
large dose cause cyanosis, tissue
hypoxia, death
Pharmacokinetic
Extensive first pass metabolism
Low availability
Onset 2-8 min
Duration 15-30 min
Several preparation available …..
Sublingual, sustained release,
transdermal, buccal
 Acute adverse effects
– Headache (prevent by paracetamol)
– orthostatic hypotension
– reflex tachycardia
– flushing
–Chronic use result in
tolerance
–Long acting preparation
usually cause tolerance
Possible causes of tolerance
 Systemic compensation
 Stimulate aldosterone release
 free radical that degradation NO
 Vascular sulfhydryl depletion
(decrease NO release)
Method to prevent tolerance
 Maintain at least 8-12 h nitrate-free interval
Pts education: for use NG SL
 Sit or lay down
 Place tablet under the tongue
(do not swallow)
 If symptom are not relief within 5 min, place
another tablet under the tongue.
 Pt may use a maximum of 3 tab over15 min
 If pain is not relieve within 20-30 min ..go to
hospital
Clinical use
 stable, unstable, variant angina
– Short acting nitrate…
prn
– NG SL, ISDN SL
 Angina prophylaxis
– Monotherapy limited by tolerance & reflex
tachycardia
– Best use combination with -blocker, CCB,
diuretic
Calcium channel blocker
(CCB)
 Increase myocardial O2 supply
– Coronary vasodilatation.. All agents
 Decrease myocardial O2 demand
– Decrease afterload and preload.. All agent
– Decrease contractility and HR.. Non-DHP
group.
CCB-Clinical Use
 Prophylaxis
 Monotherapy
– Verapamil & diltiazem may be used
– Short acting DHP CCB is generally avoided
due to reflex tachycardia.
 Combination therapy
– Often use with nitrate, beta-blocker
 DHP
– Reflex tachycardia
– Headache
– Edema
 Verapamil/diltiazem
– Bradycardia
– Heart block
– Constipation (esp. verapamil)
ADR
 Stable, unstable, variant angina
Short acting CCB increase risk of MI
Mechanism of action
Antagonize effect of catecholamine on the
heart by blocking the beta-receptor
Antianginal effect
Decrease contractility and HR
Not use in variant angina
Ex. Propranolol, metoprolol, atenolol
Hypotension
Bradycardia
Heart block
Withdrawal syndrome.. Taper dose
Bronchospasm
Other…fatigue, CNS depression, mask of
hypoglycemia, dyslipidemia
Clinical use
 Decrease O2 demand in the resting and
exercise state
 Stable, unstable angina
Combination therapy
 Nitrate & beta-blocker
 Nifedipine & beta-blocker
 CCB & nitrate
 Beta-blocker & nitrate & CCB
Related documents